Anebulo Pharmaceuticals, Inc.
ANEB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10,355 | $11,628 | $13,280 | $14,998 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $31 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $181 | $335 | $528 | $366 |
| Total Curr. Assets | $10,535 | $11,963 | $13,808 | $15,395 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $166 | $183 | $201 | $446 |
| Total NC Assets | $166 | $183 | $201 | $446 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $10,701 | $12,146 | $14,008 | $15,841 |
| Liabilities | – | – | – | – |
| Payables | $608 | $224 | $428 | $320 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $264 | $118 | $559 |
| Total Curr. Liab. | $608 | $488 | $546 | $879 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $356 | $0 | -$0 | $0 |
| Total NC Liab. | $356 | $0 | -$0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $964 | $488 | $546 | $879 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $41 | $41 | $41 | $41 |
| Retained Earnings | -$76,047 | -$73,889 | -$71,744 | -$70,068 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $85,743 | $85,505 | $85,165 | $84,989 |
| Total Equity | $9,737 | $11,658 | $13,462 | $14,962 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $10,701 | $12,146 | $14,008 | $15,841 |
| Net Debt | -$10,355 | -$11,628 | -$13,280 | -$14,998 |